NCT03055793View on ClinicalTrials.gov

Quality of Life Assessment in Greek asthmatIc Patients Treated With the Fixed Dose Combination of Budesonide / Formoterol in Clinical Practice

CompletedOBSERVATIONAL
Enrollment

1,400

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

July 31, 2017

Study Completion Date

July 31, 2017

Conditions
AsthmaQuality of LifeSatisfaction
Interventions
OTHER

budesonide formoterol fixed combination

Asthmatic patients who will be on budesonide formoterol fixed combination treatment administered by Elpenhaler device.

Trial Locations (1)

Athens 11527

7th Pulmonary Dept, Athens Chest Hospital, Athens

Sponsors
All Listed Sponsors
lead

Elpen Pharmaceutical Co. Inc.

INDUSTRY